Prospective Study
Copyright ©The Author(s) 2018.
World J Hepatol. Jan 27, 2018; 10(1): 134-141
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.134
Table 2 Hazard model of survival after liver transplant alone or simultaneous liver-kidney transplant in patients listed for liver and kidney transplant
Variable1HR95%CIP value
Transplant received
SLKref.
LTA2.85(2.21, 3.66)< 0.001
Transplant center SLK volume2
Interaction with receiving LTA vs SLK0.97(0.95, 0.99)0.010
Age (yr)1.01(1.01, 1.02)< 0.001
Male1.08(0.94, 1.24)0.285
Race
Whiteref.
Black1.17(0.98, 1.39)0.089
Other0.79(0.66, 0.94)0.007
Etiology of liver disease
Viralref.
Cryptogenic0.77(0.61, 0.98)0.033
Autoimmune0.57(0.41, 0.79)0.001
NASH0.79(0.63, 1.01)0.060
Alcoholic0.65(0.54, 0.77)< 0.001
HCC1.04(0.83, 1.30)0.721
AHN1.10(0.75, 1.63)0.621
Other0.77(0.62, 0.97)0.024
Diabetes1.23(1.08, 1.40)0.002
Dialysis1.41(1.19, 1.67)< 0.001
BMI (kg/m2)0.98(0.97, 0.99)0.003
Serum creatinine (mg/dL)0.97(0.93, 1.01)0.092
Bilirubin (mg/dL)1.00(0.98, 1.01)0.394
Albumin (mg/dL)0.88(0.81, 0.96)0.004
INR0.92(0.81, 1.05)0.224
MELD score1.00(0.99, 1.02)0.661
eGFR1.00(1.00, 1.01)0.622
Hepatic encephalopathy on wait list1.10(0.94, 1.28)0.221
Liver allograft cold ischemia time1.00(0.98, 1.02)0.811
Year of transplant0.98(0.96, 1.00)0.107